Skip to content

NMN and Medications: Interactions You Should Know

NMN interaction data is limited. What short-term trials establish, why niacin warnings differ, and how medicines and blend ingredients change the assessment.

By Marcus HaleLongevity Research Editor
Updated

5 min read · 14 sources

On this page

Published NMN tolerability studies do not establish that NMN is safe with a particular medication. They generally ask different questions from a drug-interaction study. An interaction checker returning no entry is therefore not a safety clearance, and “no well-documented dangerous interaction” is too broad to use as a personal recommendation.

The useful starting point is the exact product, full ingredient list, daily amount and medicine list. A pharmacist can assess known ingredient risks and explain where evidence is missing. FDA recommends reviewing supplements together with prescription and over-the-counter medicines because some combinations can change drug exposure or effects 12. This guide is consumer education, not an individualized medication assessment.

Affiliate partner

MadeMed

NAD+ injection & nasal spray, in 23 states

See MadeMed

What the NMN trials actually tested

An 80-person trial compared placebo with 300, 600 or 900 mg NMN daily for 60 days in healthy middle-aged adults. It reported no safety issues in its measured adverse events, laboratory and clinical outcomes 1. A separate single-dose study followed ten healthy men after 100, 250 and 500 mg doses; it was neither a long-term study nor a test of common drug combinations 4.

Another trial tested 1,250 mg daily for four weeks in 31 healthy adults, reporting no severe adverse events 14. These observations are useful within the studied settings. Small samples and short follow-up do not establish safety in pregnancy, advanced organ disease, cancer treatment or complex medication regimens.

Nor should NR studies be relabeled as NMN evidence. The often-cited eight-week NIAGEN study and the middle-aged/older-adult NR trial studied nicotinamide riboside, a different precursor 23. The NMN evidence review and NAD+ dosage guide explain those research boundaries. There is no validated “interaction-free” NMN dose established by these trials.

What's actually documented

  • Short-term NMN tolerabilityWeak evidence

    Small studies in selected adults, with limited duration and outcomes.

  • Safety with a specific medicationNone evidence

    The cited trials do not establish compatibility with an individual regimen.

  • NMN inherits niacin’s interaction listNone evidence

    Shared biology does not establish identical drug effects or risks.

  • Special-population clearanceNone evidence

    Do not extrapolate these trials to pregnancy, organ disease or complex treatment.

A tolerability study is not a drug-interaction study. No interaction-free NMN dose is established.

NMN does not inherit niacin’s full warning list

NMN, NR, nicotinamide and nicotinic acid participate in related NAD+ biology, but they are different interventions 11. High-dose nicotinic acid has documented liver, glucose and medication cautions, summarized by NIH; those warnings are not proof that NMN causes the same effects 513.

The reverse inference is also wrong: NMN’s lack of the typical niacin flush does not prove it is compatible with all medicines. Check whether a “NAD booster” actually includes nicotinic acid, nicotinamide, herbs or other active ingredients in addition to NMN. The side-effects guide distinguishes route and compound effects.

A study of nicotinamide for skin-cancer prevention is likewise not a study of NMN during chemotherapy 7. Evidence should stay attached to the substance and population actually tested rather than being transferred to everything sold as vitamin B3 support.

Liver disease and alcohol need an individual assessment

The older idea that adding NMN necessarily puts a measurable extra “burden” on the liver is not established by these trials. High-dose niacin and nicotinamide findings cannot quantify an NMN/alcohol interaction. A normal liver blood test also cannot establish that a combination is safe.

If you have liver disease, substantial alcohol use or medicines that already require liver monitoring, discuss the proposed supplement with the clinician managing that issue. Ask whether it is appropriate at all and whether any additional monitoring is useful. There is no general NMN-specific baseline-testing protocol established by the sources reviewed here. The NAD+ therapy evidence guide helps separate potential benefit from the assumption that adding a product is necessary.

Metformin and other glucose-lowering medicines

Metformin’s effects on energy-related pathways help explain why it is discussed alongside NAD+ precursors 6. Mechanistic overlap does not demonstrate a beneficial interaction or establish that the combination is harmless. Reviews of NMN and precursor metabolic outcomes also cannot substitute for an interaction trial of a person’s actual diabetes regimen 810.

Do not reduce or stop prescribed medication because a supplement is advertised as improving metabolism. The NMN/metformin guide covers the specific evidence question, while NAD+ alongside GLP-1 medicines addresses another common bundle. These combinations need assessment on their own terms, not reassurance borrowed from a healthy-volunteer trial.

Cancer treatment and immune-modifying medicines

NAD+ participates in processes relevant to both normal and malignant cells. That makes cancer-related hypotheses complex; it does not establish that a retail NMN supplement either causes cancer or is beneficial during treatment. Our NAD+ and cancer guide separates those claims.

During cancer treatment, show the oncology team the exact product before adding it. A supplement should not be assumed to support treatment simply because DNA repair or cellular energy appears in its marketing. The concern here is an unresolved clinical question rather than a proven interaction with every cancer medicine.

The same need for disease-specific assessment applies to immunosuppressive treatment. A cell experiment cannot clear a supplement for a transplant recipient or someone with autoimmune disease. The lupus guide and arthritis review distinguish laboratory findings from patient treatment outcomes.

The practical cautions

Questions for the pharmacist or treating clinician

  • What is in the full formula, and how much is taken each day?
  • Which ingredient–medicine risks are established, and where is evidence missing?
  • Do liver or kidney disease, cancer treatment, immune-modifying medicines or pregnancy change the decision?
  • Is there a supported benefit that justifies adding this product?
  • Would a simpler formulation, avoiding the supplement or evaluating the underlying symptom be more appropriate?

The other ingredients can change the answer

A medicine may interact with an added ingredient even when the NMN interaction is unknown. Our magnesium combination guide, for example, explains established magnesium-related absorption concerns. A multi-ingredient powder cannot be cleared by checking “NMN” alone.

Ingredient effects can also complicate test interpretation: the NMN/thyroid guide distinguishes NMN from biotin-related laboratory interference. Bring the Supplement Facts panel and dose rather than relying on a product name that may hide a changing formula.

What to bring to a medication review

List prescription medicines, occasional over-the-counter products and every supplement, including dose and frequency. Include planned surgery, pregnancy or breastfeeding and relevant liver, kidney or cancer history. FDA specifically advises discussing supplements in these settings 12. The pregnancy and breastfeeding guide covers the limits of NAD-related evidence there.

Ask which risks are established for the listed ingredients, which combinations have not been adequately tested and whether the proposed benefit justifies adding uncertainty. The answer may be to avoid a product, choose a simpler formulation or investigate the symptom prompting the purchase. It should not be a blanket assurance based on an empty interaction database.

Before buying more, consider the reasons people stop NMN and the actual evidence behind the goal. Our NAD+ provider comparison describes products and services; appearing there does not establish compatibility with your medication.

Frequently asked questions

Does NMN interact with medications?

The cited short-term NMN trials do not establish medication-specific compatibility. An empty interaction-checker result or a lack of a prominent warning is not proof that a combination is safe.

Can I take NMN with metformin?

Mechanistic overlap does not establish a beneficial or harmless combination. Discuss the exact product with the clinician managing the diabetes regimen; do not change prescribed treatment because of an NMN claim.

Does a normal liver blood test make NMN safe with alcohol?

No. A normal result cannot validate an untested combination. Liver disease, substantial alcohol use and existing medication monitoring warrant individual assessment; a universal NMN testing protocol is not established.

Can I take NMN during cancer treatment?

Do not infer compatibility or treatment benefit from cellular-energy or DNA-repair claims. Show the full formula to the oncology team before adding it; normal-cell research and cancer-prevention studies do not establish safety during active treatment.

Should I check only NMN on an interaction checker?

No. Added magnesium, biotin, herbs, niacin or other ingredients can change the assessment. A pharmacist needs the complete label and medicine list, including doses and occasional over-the-counter products.

References

  1. Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. https://pubmed.ncbi.nlm.nih.gov/36482258/
  2. Conze D, Brenner C, Kruger CL (2019). Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/31278280/
  3. Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. https://pubmed.ncbi.nlm.nih.gov/29599478/
  4. Irie J, Inagaki E, Fujita M, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal. https://pubmed.ncbi.nlm.nih.gov/31685720/
  5. Cooper DL, Murrell DE, Roane DS, Harirforoosh S (2015). Effects of formulation design on niacin therapeutics: mechanism of action, metabolism, and drug delivery. International Journal of Pharmaceutics. https://pubmed.ncbi.nlm.nih.gov/25987211/
  6. Rena G, Hardie DG, Pearson ER (2017). The mechanisms of action of metformin. Diabetologia. https://pubmed.ncbi.nlm.nih.gov/28776086/
  7. Chen AC, Martin AJ, Choy B, et al. (2015). A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/26488693/
  8. Chen F, et al. (2024). Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Current Diabetes Reports. https://pubmed.ncbi.nlm.nih.gov/39531138/
  9. Gallagher C, Emmanuel OO (2026). NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews. https://pubmed.ncbi.nlm.nih.gov/41655607/
  10. Oliveira-Cruz A, Macedo-Silva A, Silva-Lima D, et al. (2024). Effects of Supplementation with NAD+ Precursors on Metabolic Syndrome Parameters: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research. https://pubmed.ncbi.nlm.nih.gov/39111741/
  11. Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. https://pubmed.ncbi.nlm.nih.gov/33353981/
  12. U.S. Food and Drug Administration. Mixing Medications and Dietary Supplements Can Endanger Your Health. FDA. https://www.fda.gov/consumers/consumer-updates/mixing-medications-and-dietary-supplements-can-endanger-your-health
  13. NIH Office of Dietary Supplements. Niacin: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/Niacin-HealthProfessional/
  14. Fukamizu Y, Uchida Y, Shigekawa A, et al. (2022). Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/36002548/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.